Han-Qiang Liu

Han-Qiang Liu

Auto-generated profile, based on publicly available information

Han-Qiang Liu

The Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, The Shaanxi Provincial Key Laboratory of Environmental Health Hazard Assessment and Protection, The Shaanxi Provincial Key Laboratory of Free Radical Biology and Medicine, Department of Health Education and Management, School of Preventive Medicine, Air Force Medical University, West Changle Road No. 169, Xi’an, Shaanxi 710032, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Nutrition Research
Verified
Journal Article
Closed access
HLHan-Qiang Liu
Han-Qiang Liu
YQYa Qiu
Ya Qiu
YMYing Mu
Ying Mu
XZXian-Jiao Zhang
Xian-Jiao Zhang
LLLu Liu
Lu Liu
FWFeng Wang
Feng Wang

19 July 2011 in Cancer
Verified
Journal Article
Open access
PDF file
FZFeng Zhou
Feng Zhou
XHXianli He
Xianli He
HLHanqiang Liu
Hanqiang Liu
YZYong Zhu
Yong Zhu
TJTianbo Jin
Tianbo Jin
JXJinliang Xing
Jinliang Xing
BACKGROUND: Previous studies have demonstrated that circadian genes play a role in the development and progression of many cancers. This study aims to assess the effects of single nucleotide polymorphisms (SNPs) in circadian genes on recurrence and survival of colorectal cancer (CRC) patients.METHODS: Nine functional SNPs in 3 genes (CLOCK, NPAS2, and BMAL1) on the circadian positive feedback loop were selected and genotyped using the Sequenom iPLEX genotyping system in a cohort of 411 resected Chinese CRC patients. Multivariate Cox proportional hazards model and Kaplan‐Meier curve were used for the prognosis analysis.RESULTS: The authors identified 2 SNPs in the CLOCK gene to be significantly associated with CRC overall survival. SNP rs3749474 exhibited a significant association with survival of CRC patients in the additive model (hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.37‐0.81; P = .003). In addition, patients carrying the heterozygous variant of rs1801260 had significantly increased overall survival compared with those carrying homozygous wild‐type genotype (HR, 0.31; 95% CI, 0.11‐0.88; P = .03). Findings from functional assay provided further biological support for these significant associations. Stratified analysis found no modifying effect of chemotherapy on the prognostic significance of both SNPs. Moreover, we observed cumulative effects of these 2 SNPs on CRC overall survival (P for trend = .01). Compared with patients carrying no unfavorable genotypes, those carrying 2 unfavorable genotypes had a 2.92‐fold increased risk of death (P = .03).CONCLUSIONS: The results suggest for the first time that CLOCK gene polymorphisms may serve as an independent prognostic marker for CRC patients. Cancer 2012;. © 2011 American Cancer Society.

28 September 2023 in ACS Omega
Verified
Journal Article
Open access
MLMeng-Ying Li
Meng-Ying Li
JDJia-Qi Duan
Jia-Qi Duan
XWXiao-Hui Wang
Xiao-Hui Wang
MLMeng Liu
Meng Liu
QYQiao-Yi Yang
Qiao-Yi Yang
FWFeng Wang
Feng Wang
Inulin, a commonly used dietary fiber supplement, is capable of modulating the gut microbiome. Chronic inflammation resulting from metabolic abnormalities and gut flora dysfunction plays a significant role in the development of type 2 diabetes mellitus (T2DM). Our research has demonstrated that inulin administration effectively reduced colonic inflammation in T2DM mice by inducing changes in the gut microbiota and increasing the concentration of butyric acid, which in turn modulated the function of enteric glial cells (EGCs). Experiments conducted on T2DM mice revealed that inulin administration led to an increase in the Bacteroidetes/Firmicutes ratio and the concentration of butyric acid in the colon. The anti-inflammatory effects of altered gastrointestinal flora and its metabolites were further confirmed through fecal microbiota transplantation. Butyric acid was found to inhibit the activation of the κB inhibitor kinase β/nuclear factor κB pathway, regulate the expression levels of interleukin-6 and tumor necrosis factor-α, suppress the abnormal activation of EGCs, and prevent the release of inflammatory factors by EGCs. Similar results were observed in vitro experiments with butyric acid. Our findings demonstrate that inulin, by influencing the intestinal flora, modifies the activity of EGCs to effectively reduce colonic inflammation in T2DM mice.

20 September 2016 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
XTXu Tang
Xu Tang
BZBin Zeng
Bin Zeng
JGJian-Kun Gao
Jian-Kun Gao
HLHan-Qiang Liu
Han-Qiang Liu
LY2835219 is a dual inhibitor to CDK4 and CDK6. This study was to prepare LY2835219-loaded chitosan nanoparticles (CNP/LY) and LY2835219-loaded hyaluronic acid-conjugated chitosan nanoparticles (HACNP/LY) and revealed their anticancer effect and influence on p16-CDK4/6-pRb pathway against colon cell line. The nanoparticle sizes of CNP/LY and HACNP/LY were approximately195±39.6 nm and217±31.1 nm, respectively. The zeta potentials of CNP/LY and HACNP/LY were37.3±1.5 mV and30.3±2.2 mV, respectively. And the preparation process showed considerable drug encapsulation efficiency and loading efficiency. LY2835219, CNP/LY, and HACNP/LY inhibited HT29 cell proliferation with 0.68, 0.54, and 0.30 μM of IC50, respectively. G1 phase was arrested by LY2835219 and its formulations. Furthermore, inhibition of CDK4/6 by LY2835219 formulations induced CDK4, CDK6, cyclin D1, and pRb decrease and p16 increase at both protein and mRNA levels. Overall, nanoparticle formulated LY2835219 could enhance the cytotoxicity and cell cycle arrest, and HACNP/LY strengthened the trend furtherly compared to CNP/LY. It is the first time to demonstrate the anticancer effect and mechanism against HT29 by LY2835219 and its nanoparticles. The drug and its nanoparticle formulations delay the cell growth and arrest cell cycle through p16-CDK4/6-pRb pathway, while the nanoparticle formulated LY2835219 could strengthen the process.